Abstract:OBJECTIVE:To study the effects of 1, 25-dihydroxyvitamin D(3) (VD(3)) on the expression of vitamin D receptor (VDR), receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) in human periodontal ligament cells (hPDLC) populations and to analyze the potential mechanisms.METHODS:Twelve hPDLC populations were primarily established from 12 donors individually. Two samples of each hPDLC population of passage three were treated respectively with 10(-8) mol/L VD(3) (V D(3) group) or 0.1% absolute ethyl alcohol as controls (control group). Six days later, the mRNA expression levels of VDR, RANKL and OPG in the samples were determined with real-time quantitative RT-PCR. The DNA base sequences upstream to the transcription start site of RANKL gene were also analyzed.RESULTS:Compared with the control group, the mRNA expression level of VDR increased significantly in the VD(3) group (P = 0.003), averagely (3.04 +/- 1.06) times of that in the control group; the mRNA expression level of RANKL was also up-regulated by VD(3) (P = 0.001), 9.82 (0.75-119.18) times of that in the control group; the OPG expression level was (94.48 +/- 39.15)% of the controls (P = 0.136); OPG/RANKL ratio was down-regulated in the VD(3) group to averagely 10.36% (1.01%-138.00%) of the controls (P = 0.003). No mutation was found in the DNA fragments upstream to the transcription start site in the RANKL gene and the genotypes of the polymorphism at -1832 (rs7984870, C/G) were not shown to be significantly related to the RANKL mRNA expression level.CONCLUSIONS:In hPDLC, VD(3) can significantly increase the mRNA expression level of VDR; VD(3) can increase RANKL mRNA expression level to decrease OPG/RANKL ratio, but it has little effect on OPG mRNA expression. The big differences of the RANKL mRNA regulation in response to VD(3) treatment among hPDLC populations may not be associated with the DNA sequences upstream to the transcription start site in the RANKL gene.

The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1α,25-dihydroxyvitamin D3

[Expression of OPG and RANKL at Protein Level in Human Periodontal Ligament Cells and the Effect of 1alpha,25(oh)(2) Vitamin D(3) on the Secretion of OPG Protein in Vitro].

The Semi-Quantitative RT-PCR Study on the Expression of OPG and RANKL in Human Periodontal Ligament Cells Induced by 1alpha, 25 (OH)2 Vitamin D3

Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells.

Effect of 1,25-(OH)2 D3 on the expression of amelogenin and ameloblastin secreted by porcine ameloblasts

Effects of Calcitriol on the Expression of Vitamin D Receptor. RANKL and Osteoprotegerin in Human Periodontal Ligament Cells

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Isolation, Characterization and Investigation of Differentiation Potential of Human Periodontal Ligament Cells and Dental Follicle Progenitor Cells and Their Response to BMP-7 in Vitro

Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta.

Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

1?,25-dihydroxyvitamin D3 promotes early osteogenic differentiation of PDLSCs and a 12-year follow-up case of early-onset vitamin D deficiency periodontitis

Activation Of Cannabinoid Receptor Cb2 Regulates Osteogenic And Osteoclastogenic Gene Expression In Human Periodontal Ligament Cells

Effects of Osteoblastic Growth Peptide on the Proliferation and Total Protein Content in Cultured Human Periodontal Ligament Cells

Human Periodontal Ligament Cells Express Osteoblastic Phenotypes under Intermittent Force Loading in Vitro.

Comparation of 1α, 25-dihydroxyvitamin D3-stimulated interleukin 1 receptor type Ⅰ expression in young and aged human periodontal ligament cells

ANGPTL4 Regulates the Osteogenic Differentiation of Periodontal Ligament Stem Cells.

HOXA10 Inhibit the Osteogenic Differentiation of Periodontal Ligament Stem Cells by Regulating Β-Catenin Localization and DKK1 Expression

Extending the Vitamin D Pathway to Vitamin D3 and CYP27A1 in Periodontal Ligament Cells

Effect of Cells Derived from Periodontal Ligament Tissue on Bone Formation

Effects of Mechanical Stretching Force on Osteoblast-Like Function of Human Periodontal Ligament Cells in Vitro

[Indication of Osteoprotegerin (OPG) and Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) in Gingival Crevicular Fluid to Remodeling of Alveolar Bone During Retention].